Data News > MRK, LABD, UVXY, INFY, UVIX showing five-day downward plunge
MRK is trading DOWN for the last 4 days, and it at trading at $82.32 with volume of 6,341,658 and a one day change of $-0.69 (-0.83%). Merck & Co., Inc. has a 52-week low of 84.42 and a 52-week high of $132.68. The business's 50-day moving average price is $97.15 and its 200 day moving average price is $111.21. The firm has a market cap of $210 million, a P/E ratio of 144.51, and a beta of 0.40.
LOS ANGELES , Feb. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. ("Merck" or "the Company") (NYSE: MRK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 3, 2022, and February 3, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025. NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=130156&wire=1 or contact Joseph E. Levi, Esq. NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or "the Company") (NYSE:MRK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Merck securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period"). RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--WELIREG Receives First European Commission Approval for Two Indications. NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025.
For more information on MRK:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
LABD is trading DOWN for the last 4 days, and it at trading at $6.64 with volume of 5,649,576 and a one day change of $-0.18 (-2.64%). Direxion Daily S&P Biotech Bear 3X Shares has a 52-week low of 4.77 and a 52-week high of $10.95. The business's 50-day moving average price is $6.73 and its 200 day moving average price is $6.47. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -2.64.
For more information on LABD:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
UVXY is trading DOWN for the last 4 days, and it at trading at $17.81 with volume of 5,250,549 and a one day change of $-0.07 (-0.36%). ProShares Ultra VIX Short-Term Futures ETF has a 52-week low of 17.80 and a 52-week high of $65.87. The business's 50-day moving average price is $19.75 and its 200 day moving average price is $24.27. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -2.22.
For more information on UVXY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
INFY is trading DOWN for the last 4 days, and it at trading at $21.33 with volume of 2,649,751 and a one day change of $-0.25 (-1.14%). Infosys Limited has a 52-week low of 15.82 and a 52-week high of $23.63. The business's 50-day moving average price is $22.36 and its 200 day moving average price is $20.96. The firm has a market cap of $90 million, a P/E ratio of 22.20, and a beta of 0.64.
Establishes a new Global Capability Center in India to drive growth and deliver future-ready capabilities and services powered by Infosys Topaz BENGALURU, India , Feb. 18, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a strategic, long-term collaboration with Lufthansa Group (LHG), a global aviation group, and Lufthansa Systems GmbH (LSY), leading airline IT provider, to accelerate digital transformation and drive innovation in the aviation industry. As part of the engagement, LSY and Infosys will establish a dedicated Global Capability Center (GCC) in Bengaluru, India.
For more information on INFY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
UVIX is trading DOWN for the last 4 days, and it at trading at $26.89 with volume of 2,391,127 and a one day change of $-0.16 (-0.59%). 2x Long VIX Futures ETF has a 52-week low of 27.20 and a 52-week high of $199.70. The business's 50-day moving average price is $31.85 and its 200 day moving average price is $49.95. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -3.62.
For more information on UVIX:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
MRK, LABD, UVXY, INFY, UVIX showing five-day downward plunge
By KlickAnalytics Data Insights | February 18, 2025 10:44AM ET
Merck & Co., Inc. (MRK)
MRK is trading DOWN for the last 4 days, and it at trading at $82.32 with volume of 6,341,658 and a one day change of $-0.69 (-0.83%). Merck & Co., Inc. has a 52-week low of 84.42 and a 52-week high of $132.68. The business's 50-day moving average price is $97.15 and its 200 day moving average price is $111.21. The firm has a market cap of $210 million, a P/E ratio of 144.51, and a beta of 0.40.
Top news headlines for MRK
For more information on MRK:
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
LABD is trading DOWN for the last 4 days, and it at trading at $6.64 with volume of 5,649,576 and a one day change of $-0.18 (-2.64%). Direxion Daily S&P Biotech Bear 3X Shares has a 52-week low of 4.77 and a 52-week high of $10.95. The business's 50-day moving average price is $6.73 and its 200 day moving average price is $6.47. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -2.64.
For more information on LABD:
ProShares Ultra VIX Short-Term Futures ETF (UVXY)
UVXY is trading DOWN for the last 4 days, and it at trading at $17.81 with volume of 5,250,549 and a one day change of $-0.07 (-0.36%). ProShares Ultra VIX Short-Term Futures ETF has a 52-week low of 17.80 and a 52-week high of $65.87. The business's 50-day moving average price is $19.75 and its 200 day moving average price is $24.27. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -2.22.
For more information on UVXY:
Infosys Limited (INFY)
INFY is trading DOWN for the last 4 days, and it at trading at $21.33 with volume of 2,649,751 and a one day change of $-0.25 (-1.14%). Infosys Limited has a 52-week low of 15.82 and a 52-week high of $23.63. The business's 50-day moving average price is $22.36 and its 200 day moving average price is $20.96. The firm has a market cap of $90 million, a P/E ratio of 22.20, and a beta of 0.64.
Top news headlines for INFY
For more information on INFY:
2x Long VIX Futures ETF (UVIX)
UVIX is trading DOWN for the last 4 days, and it at trading at $26.89 with volume of 2,391,127 and a one day change of $-0.16 (-0.59%). 2x Long VIX Futures ETF has a 52-week low of 27.20 and a 52-week high of $199.70. The business's 50-day moving average price is $31.85 and its 200 day moving average price is $49.95. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of -3.62.
For more information on UVIX:
This article was generated by KlickAnalytics data insight content engine.
To view full story, Upgrade to PRO plan!
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.